Mata Nathan L.'s Form 4 filing
Belite Bio, Inc (BLTE) · filed Apr 20, 2026
- Accession no.
- 0001193125-26-164014
- Filed
- Apr 20, 2026
- Trade date
- Apr 17, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions. Open-market sales total $161.6K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mata Nathan L.CIK 0002013987 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 17, 2026 | American depositary share | SSaleDisposed | −32 | $158.46F3 | −$5,070.72 | 14,634 | Direct | |
| Apr 17, 2026 | American depositary share | SSaleDisposed | −52 | $159.38F4 | −$8,287.76 | 14,582 | Direct | |
| Apr 17, 2026 | American depositary share | SSaleDisposed | −226 | $160.55F5 | −$36,284.3 | 14,356 | Direct | |
| Apr 17, 2026 | American depositary share | SSaleDisposed | −274 | $161.41F6 | −$44,226.34 | 14,082 | Direct | |
| Apr 17, 2026 | American depositary share | SSaleDisposed | −216 | $162.48F7 | −$35,095.68 | 13,866 | Direct | |
| Apr 17, 2026 | American depositary share | SSaleDisposed | −200 | $163.33F8 | −$32,666 | 13,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents the weighted average price of shares sold at prices that ranged from $158.09 to $158.89. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of shares sold at prices that ranged from $159.07 to $159.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of shares sold at prices that ranged from $160.00 to $160.995. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average price of shares sold at prices that ranged from $161.01 to $161.92. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents the weighted average price of shares sold at prices that ranged from $162.01 to $162.55. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents the weighted average price of shares sold at prices that ranged from $163.27 to $163.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.